Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

165 results about "Streptococcus mutans" patented technology

Streptococcus mutans is a facultatively anaerobic, gram-positive coccus (round bacterium) commonly found in the human oral cavity and is a significant contributor to tooth decay. It is part of the "streptococci" (plural, non-italic lowercase), an informal general name for all species in the genus Streptococcus.The microbe was first described by J Kilian Clarke in 1924.

SnO2 / SnS2 / Ag2S nano material for whitening and sterilizing teeth through piezoelectric electro-catalysis

PendingCN119632857AEasy to operateNo harm to the surface structure of the teethCosmetic preparationsMaterial nanotechnologyHeterojunctionTooth whitening
The invention discloses a SnO2 / SnS2 / AgS nano material with piezoelectric electro-catalytic tooth whitening and sterilizing performance and a preparation method and application thereof, and the preparation method comprises the following steps: (1) dripping a silver nitrate aqueous solution into a prepared SnO2 / SnS2 nano material aqueous dispersion, carrying out hydro-thermal treatment for 2 hours, centrifuging, washing and drying to obtain a SnO2 / SnS2 / Ag2S ternary semiconductor heterojunction nano material; (2) food indigo is adopted to simulate tooth surface pigments, piezoelectric electro-catalytic degradation is carried out by using the SnO2 / SnS2 / Ag2S ternary semiconductor heterojunction nanomaterial, and the pigment degradation efficiency can reach 95% or above; (3) the SnO2 / SnS2 / Ag2S heterojunction nanomaterial is used for piezoelectric electro-catalysis treatment of the streptococcus mutans pellicle, and the antibacterial rate of the pellicle can reach 90% or above; and (4) compared with a 3% H2O2 aqueous solution for treating the enamel surface structure, the SnO2 / SnS2 / Ag2S nano-material piezoelectric electro-catalysis treatment of teeth has small damage to the enamel surface structure. According to the invention, more nano materials with tooth whitening and sterilizing performance and the preparation method thereof are provided, so that the problems of single variety, single preparation method, low electron-hole separation efficiency and large side effect of the existing tooth whitening and sterilizing nano materials are solved.
Owner:HARBIN INST OF TECH

Preparation method and application of Lactobacillus paracasei IOB413 metagenic powder

The invention provides a preparation method and application of casei paracasei IOB413 after-generation powder, and relates to the field of microorganisms. Tartary buckwheat is used as a solid-state fermentation culture medium, and the lactobacillus paracasei IOB413 is fermented and then crushed to prepare the lactobacillus paracasei IOB413 after-generation powder with high flavone content. The flavonoid content of the metagenic powder prepared by the method is far higher than that in tartary buckwheat and casei paracasei IOB413, the levels of tumor necrosis factor alpha (TNF-alpha) and interleukin (IL-6) can be reduced, the level of anti-inflammatory factor interleukin (IL-10) can be increased, the gingival index and the dental plaque index can be reduced, the growth of streptococcus mutans can be inhibited to a certain extent, and the metagenic powder can be used for preventing and treating the dental plaque. The oral micro-ecology is improved.
Owner:TIANJIN INNOORIGIN BIOLOGICAL TECH CO LTD +1

Viable bacterium preparation of lactobacillus paracasei strain as well as preparation method and application of viable bacterium preparation

The invention relates to the technical field of microorganisms, in particular to a viable bacterium preparation of a lactobacillus paracasei strain as well as a preparation method and application of the viable bacterium preparation. The viable bacterium preparation comprises a lactobacillus paracasei strain and auxiliary materials, and the preservation number of the lactobacillus paracasei strain is CGMCC (China General Microbiological Culture Collection Center) No.27974. The viable bacterium preparation can inhibit the growth of streptococcus mutans, reduce the formation of a dental plaque biofilm caused by the streptococcus mutans, reduce the content of a mature dental plaque biofilm, inhibit the level of water-insoluble exopolysaccharides generated by the streptococcus mutans, reduce the expression quantity of cariogenic genes gtfB, gtfC, gtfD, ftf and LuxS of the streptococcus mutans, improve the cariogenic activity of the streptococcus mutans and improve the cariogenic activity of the streptococcus mutans. The adhesion rate of streptococcus mutans on a hydroxyapatite tooth model is reduced, and a beneficial in-vitro probiotic function is achieved.
Owner:COREE CO LTD

Application of composition in preparation of drugs or daily chemical products for preventing decayed teeth

The invention discloses application of a composition to preparation of a medicine or daily chemical product for preventing decayed teeth. Three medicinal materials of the active ingredient three-fruit soup in the mouthwash all belong to traditional Chinese medicine resources with homology of medicine and food, the ingredients are safe and do not have side effects on a human body, and the mouthwash has a relatively good inhibition effect on main pathogenic bacteria such as streptococcus mutans, escherichia coli and staphylococcus aureus in an oral cavity after being mixed according to a specific proportion. According to the invention, polysaccharide is adopted to inhibit the astringency of the three-fruit soup for the first time, and the prepared three-fruit soup mouthwash is good in taste and has a considerable development prospect when being applied to caries prevention of children.
Owner:CHENGDU MEDICAL COLLEGE

Purified cow milk antibacterial peptide produced by fermentation method and preparation method thereof

The invention discloses a preparation method and application of a cow milk antibacterial peptide with wide inhibitory activity on gram-positive bacteria and gram-negative bacteria by a fermentation method, the cow milk antibacterial peptide is prepared by taking milk protein as a raw material through a microbial fermentation method and a multi-stage membrane separation and purification process, the yield of the cow milk antibacterial peptide prepared by the method can reach 18-30%, and the yield of the cow milk antibacterial peptide prepared by the method can reach 18-30%. And the peptide content in the product is 60-85%. The cow milk antibacterial peptide prepared by the preparation method disclosed by the invention has inhibitory activity on gram-positive bacteria and gram-negative bacteria. The prepared cow milk antibacterial peptide can be used for preparing drugs and / or health care products, food and skin care products for preventing and / or reducing infectious diseases caused by escherichia coli, staphylococcus aureus, pseudomonas aeruginosa, porphyromonas gingivalis and streptococcus mutans, can also be used as a food preservative, an oral bacteriostatic agent, a preservative and the like, and has a good application prospect.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Probiotic composition for preventing and / or inhibiting oral pathogens as well as derivative product, preparation method and application thereof

The invention provides a probiotic composition for preventing and / or inhibiting oral pathogens as well as a derivative product, a preparation method and application of the probiotic composition, and belongs to the technical field of oral care. The probiotic composition comprises the following bacterial strains in parts by mass: 90 to 0.45 part of a lactobacillus rhamnosus bacterial strain A2114, 10 to 0.3 part of a plant lactobacillus bacterial strain A2124, 80 to 0.4 part of a pediococcus pentosaceus bacterial strain A2135, 250 to 0.25 part of a lactobacillus reuteri bacterial strain A21350, and 40 to 0.2 part of a plant lactobacillus bacterial strain A2109. The probiotic composition or the metabolite thereof can effectively inhibit oral pathogens such as streptococcus mutans, porphyromonas gingivalis, helicobacter pylori, escherichia coli and staphylococcus aureus. Therefore, the probiotic composition or the metabolite thereof shows a good application prospect in the aspects of preventing and relieving oral problems such as decayed teeth, periodontitis and ozostomia.
Owner:SICHUAN AISHENG LIFE TECHNOLOGY CO LTD +2

Lactobacillus casei GG002 and application of bacteriocin solution, freeze-dried powder and metagen thereof in treatment of oral ulcer

The invention provides a Lactobacillus casei GG002, a bacteriocin solution of the Lactobacillus casei GG002, freeze-dried powder of the Lactobacillus casei GG002 and application of the bacteriocin solution and the freeze-dried powder of the Lactobacillus casei GG002 to treatment of oral ulcer, and belongs to the technical field of microorganisms. The invention finds that the lactobacillus casei GG002 can inhibit streptococcus mutans, fusobacterium nucleatum and porphyromonas gingivalis, and has the effect of treating oral ulcer. The invention further provides a bacteriocin solution, freeze-dried powder and metagen of the casei casei GG002, and the bacteriocin solution, the freeze-dried powder and the metagen can be used for effectively treating the oral ulcer.
Owner:天津芯源生物科技有限公司 +1

Lactobacillus paracasei strain as well as fermentation product and application thereof

The invention relates to the technical field of microorganisms, in particular to a lactobacillus paracasei strain as well as a fermentation product and application thereof. The preservation number of the lactobacillus paracasei strain is CGMCC (China General Microbiological Culture Collection Center) No.27974. The Lactobacillus paracasei can inhibit the growth of Streptococcus mutans, reduce the formation of a dental plaque biofilm caused by Streptococcus mutans, reduce the content of a mature dental plaque biofilm, inhibit the level of water-insoluble exopolysaccharides generated by Streptococcus mutans, and reduce the expression quantity of cariogenic genes gtfB, gtfC, gtfD, ftf and LuxS of Streptococcus mutans, and can be used for fermentation production of fermented milk. And oat milk and other fermentation products.
Owner:COREE CO LTD

Phytobacterium plantarum TRT-01 with anti-inflammatory and bacteriostatic functions as well as preparation method and application of phytobacterium plantarum TRT-01

The invention relates to the field of microorganisms, in particular to lactobacillus plantarum TRT-01 with anti-inflammatory and bacteriostatic functions as well as a preparation method and application of the lactobacillus plantarum TRT-01, the lactobacillus plantarum TRT-01 is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC No.32237, and the preservation date is October 17, 2024. The plant lactobacillus has broad-spectrum bacteriostatic activity on 10 pathogenic bacteria such as helicobacter pylori, streptococcus mutans and the like, and can regulate Th1 / Treg immune balance and relieve inflammatory response by inducing dendritic cells to secrete cell factors IL-10 and IL-12, inducing T cells to secrete cell factors TGF-beta and IFN-gamma and inhibiting secretion of cell factors IL-6 at the same time. Therefore, the plant lactobacillus TRT-01 disclosed by the invention can be used for preparing a composition with anti-inflammatory and bacteriostatic effects, is suitable for the fields of medicines, foods, health-care products and the like, and is particularly suitable for developing a microbial preparation with a probiotic effect.
Owner:BEIJING TONGRENTANG XINGAN HEALTH TECH CO LTD

Phytobacterium plantarum BR32 with functions of preventing decayed teeth and improving inflammation and application of phytobacterium plantarum BR32

The invention relates to the technical field of microorganisms, in particular to plant lactobacillus BR32 with functions of preventing decayed teeth and improving inflammation and application of the plant lactobacillus BR32. The plant lactobacillus BR32 with the functions of preventing decayed teeth and improving inflammation, provided by the invention, has the preservation number of CGMCC No.32836, has an inhibiting effect on the growth of oral pathogens such as streptococcus mutans, candida albicans and porphyromonas gingivalis, is high in oxidation resistance, is beneficial to continuous oral cavity stability maintenance through a synergistic effect, also has relatively high hydrophobicity and self-agglutination capability, and can be used for preparing oral cavity health-care products. The compound is low in tooth environment corrosion, high in lysozyme tolerance and good in oral colonization capacity, does not have a hemolysis phenomenon in in-vitro hemolysis culture, is sensitive to common antibiotics and has relatively high food safety. The invention further provides a microbial agent, a probiotic product, a functional food, a fermented product, a bacteriostatic agent and an oral product containing the plant lactobacillus BR32 with the functions of preventing the decayed teeth and improving the inflammation, and the effects of preventing the decayed teeth, improving the inflammation, preventing dental plaque, relieving oral ulcer and the like are achieved.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Preparation method of keratinized gingival repair stent

The invention provides a preparation method of a keratinized gingival repair scaffold, which comprises the following steps: dispersing biological microsphere active powder in protein slurry to obtain a loose surface stock solution, freeze-drying the loose surface stock solution and an acellular matrix material, and cross-linking twice to obtain the keratinized gingival repair scaffold with a loose surface and a compact surface. During use, the loose surface of the porous sponge structure is in contact with a wound surface, so that adhesion and ingrowth of tissue cells are facilitated, and the compact surface can seal and protect the wound to a certain extent in an open healing environment. The obtained keratinized gingival repair stent can effectively maintain, regulate and control the pH environment in the oral cavity, is bacteriostatic and antibacterial, inhibits the growth of acid-producing and dental caries-causing bacteria such as streptococcus mutans, has the capabilities of stopping bleeding, promoting bone growth and periodontal ligament regeneration, and inhibits periodontal epithelium retraction.
Owner:EXCELLENCE MEDICAL TECH SUZHOU CO LTD +1

Composition and application thereof in caries prevention

The invention provides a composition and application thereof in caries prevention. The composition comprises fluoride and polypeptide, the concentration of F <-> in the fluoride in the composition is 1.79 to 7.14 mM; the concentration of the polypeptide in the composition is 1.56-12.5 [mu] M, and the amino acid sequence of the polypeptide is as shown in SEQ ID NO: 1. The natural advantage that polypeptide is not prone to drug resistance is utilized, the risk that streptococcus mutans and other bacteria generate drug resistance is greatly reduced, the inhibition effect of fluoride on streptococcus mutans can be remarkably enhanced, and a good anti-caries effect can be achieved under the low concentration (F <-> is 1.79-7.14 mM) of fluoride. Moreover, adverse effects on probiotics in the oral cavity are avoided, and the oral micro-ecological balance can be adjusted. Therefore, the composition disclosed by the invention is suitable for preparing products for preventing caries, inhibiting streptococcus mutans and regulating oral micro-ecological balance.
Owner:HAOYIKANG BIOMATERIALS (GUANGZHOU) CO LTD

Postbiotic composition for effectively inhibiting dental caries in oral cavity and preparation method thereof

The invention belongs to the technical field of biomedical treatment and biological fermentation, discloses a metagen composition for effectively inhibiting oral dental caries and application thereof, and aims to solve the problems of great side effect, weak effect and unknown mechanism of the existing dental caries prevention and treatment means. The composition is prepared by mixing a metagen 1 which is prepared by fermenting lactobacillus salivarius Postbio-YY with a metagen 2 which is prepared by fermenting lactococcus lactis Postbio-F3 and lactobacillus paracasei Postbio-P6 step by step. In the preparation process, the active ingredients are reserved by accurately controlling the fermentation pH, time and pasteurization parameters. The composition can be prepared into multiple dosage forms such as toothpaste and the like, can remarkably inhibit the growth of streptococcus mutans and destroy the thallus structure, inhibits biofilm and exopolysaccharide synthesis by down-regulating fimI, wcaJ and wcae genes, is safe and free of side effects, and provides an efficient scheme for decayed tooth prevention and treatment.
Owner:YANGZHOU PERFECT DAILY CHEM

Antibacterial peptide and application thereof

The invention discloses an antibacterial peptide and application thereof. The antibacterial peptide comprises one or more of an antibacterial peptide PFK with an amino acid sequence as shown in SEQ ID NO: 1, an antibacterial peptide PVK with an amino acid sequence as shown in SEQ ID NO: 2 and an antibacterial peptide PIK with an amino acid sequence as shown in SEQ ID NO: 3. The antibacterial peptides PFK, PVK and PIK disclosed by the invention have antibacterial effects on porphyromonas gingivalis, streptococcus mutans, acinetobacter baumannii, escherichia coli and staphylococcus aureus, and the antibacterial peptides PFK, PVK and PIK have relatively low hemolytic activity and relatively low cytotoxicity, so that the antibacterial peptides PFK, PVK and PIK can be used for preparing biological antibacterial preparations, anti-infection drugs or oral products.
Owner:SHANGHAI HI TECH BIOENG

Selective culture medium for streptococcus mutans and application of selective culture medium

The invention provides selective culture and application of streptococcus mutans, and belongs to the technical field of biological culture media. Aiming at the problem that an existing MSB-15 culture medium is low in positive rate when being used for culturing streptococcus mutans, the selective culture medium comprises a basic culture medium and a specific addition factor, and the basic culture medium comprises 15g / L of peptone, 5g / L of yeast extract, 15g / L of agar and 1000mL of distilled water; the specific addition factors comprise 0.2 g / L of L-cysteine, 0.1 g / L of sodium sulfite, 20 g / L of sodium acetate and 0.2 U / mL of bacitracin, and the mass concentration of sucrose is 10%; when the selective culture medium is used for streptococcus mutans culture, more accurate bacterial colony counting and larger bacterial colony diameter can be formed, typical'sugar particle 'crystals exist around bacterial colonies, distinguishing is facilitated, and the selective culture medium has unique screening advantages and has good clinical application value.
Owner:SICHUAN UNIV

Lactobacillus paracasei strain and application thereof

The invention relates to the technical field of microorganisms, in particular to a lactobacillus paracasei strain and application thereof. The preservation number of the lactobacillus paracasei strain is CGMCC (China General Microbiological Culture Collection Center) No.27975. The lactobacillus paracasei disclosed by the invention can tolerate an oral environment, inhibit proliferation of streptococcus mutans and remarkably inhibit adhesion of the streptococcus mutans on a hydroxyapatite tooth model; the level of producing water-insoluble exopolysaccharides by streptococcus mutans is reduced, the formation of a dental plaque biofilm caused by streptococcus mutans is effectively reduced, the content of a mature dental plaque biofilm is reduced, and the biofilm is not easy to form; the expression quantity of cariogenic genes gtfB, gtfC, gtfD, ftf and LuxS of streptococcus mutans can be obviously reduced.
Owner:COREE CO LTD

Polypeptide and application thereof in preparation of streptococcus mutans inhibitor

The invention provides a polypeptide and application thereof in preparation of a streptococcus mutans inhibitor. The amino acid sequence of the polypeptide is shown as SEQ ID NO: 1, and the polypeptide not only can effectively inhibit streptococcus mutans, but also is non-toxic to cells, and is suitable for preparing oral products which are excellent in antibacterial effect and can be used for a long time, so that oral diseases, especially caries, are prevented and treated. Moreover, the polypeptide disclosed by the invention is short in length, small in chemical synthesis difficulty, capable of being directly synthesized into a high-purity product, clear in effect and wide in application.
Owner:HAOYIKANG BIOMATERIALS (GUANGZHOU) CO LTD

Lactobacillus paracasei and application thereof

The invention relates to the field of microorganisms, and discloses lactobacillus paracasei and application thereof. The strain can degrade cholesterol and inhibit the growth and reproduction of streptococcus mutans; in addition, the strain not only has relatively strong acid production capacity, but also can ferment butter under a low-temperature condition, so that the butter with strong and harmonious flavor is obtained.
Owner:COFCO NUTRITION AND HEALTH RESEARCH INSTITUTE CO LTD +1

Viable bacterium preparation with effect of preventing or treating decayed teeth as well as preparation method and application of viable bacterium preparation

The invention relates to the technical field of microorganisms, in particular to a viable bacterium preparation with the effect of preventing or treating decayed teeth as well as a preparation method and application of the viable bacterium preparation. The viable bacterium preparation comprises a lactobacillus paracasei strain and auxiliary materials, and the preservation number of the lactobacillus paracasei strain is CGMCC (China General Microbiological Culture Collection Center) No.27975. The viable bacterium preparation can inhibit the proliferation of streptococcus mutans and significantly inhibit the adhesion of streptococcus mutans on a hydroxyapatite tooth model; the level of producing water-insoluble exopolysaccharides by streptococcus mutans is reduced, the formation of a dental plaque biofilm caused by streptococcus mutans is effectively reduced, the content of a mature dental plaque biofilm is reduced, and the biofilm is not easy to form; the expression quantity of cariogenic genes gtfB, gtfC, gtfD, ftf and LuxS of streptococcus mutans can be obviously reduced.
Owner:COREE CO LTD

Preparation method of blue light response fluorine-nitrogen co-doped zinc oxide antibacterial agent

The invention discloses a preparation method of a blue light response fluorine-nitrogen co-doped zinc oxide antibacterial agent, relates to the technical field of dental caries repair materials, and solves the problem of secondary caries caused by the fact that a dental clinical repair material does not have an antibacterial effect. Comprising the following steps: adding a zinc nitrate hexahydrate solution containing ammonium fluoride and urea into a concentrated sodium hydroxide solution, and stirring to obtain a precursor solution; washing the precursor solution with deionized water and absolute ethyl alcohol, performing suction filtration, drying in a drying oven, and annealing to obtain fluorine-nitrogen co-doped zinc oxide; the fluorine-nitrogen co-doped zinc oxide prepared by the invention has a relatively good antibacterial effect on the main bacterium streptococcus mutans in the oral cavity, meanwhile, the fluorine-nitrogen co-doped zinc oxide shows good biocompatibility, the antibacterial effect is improved under the illumination of a dental curing lamp, and the technical problem that the existing dental composite resin cannot realize long-term bacteriostasis is solved.
Owner:SOUTHWEST JIAOTONG UNIV

Antimicrobial peptides and their applications

The present invention discloses an antimicrobial peptide and its application, wherein the antimicrobial peptide comprises one or more of an antimicrobial peptide PFK having an amino acid sequence as shown in SEQ ID NO: 1, an antimicrobial peptide PVK having an amino acid sequence as shown in SEQ ID NO: 2, and an antimicrobial peptide PIK having an amino acid sequence as shown in SEQ ID NO: 3. The antimicrobial peptides PFK, PVK and PIK of the present invention have antimicrobial effects on Porphyromonas gingivalis, Streptococcus mutans, Acinetobacter baumannii, Escherichia coli and Staphylococcus aureus, and the antimicrobial peptides PFK, PVK and PIK have low hemolytic activity and low cytotoxicity, and can be used to prepare biological antimicrobial preparations, anti-infective drugs or oral products.
Owner:SHANGHAI HI TECH BIOENG

Enzyme catalysis system with function of targeted inhibition of growth of streptococcus mutans as well as preparation and application of enzyme catalysis system

The invention belongs to the technical field of synthesis and antibiosis of nano-enzyme catalysis systems, and discloses an enzyme catalysis system with a function of targeted inhibition of growth of streptococcus mutans as well as preparation and application of the enzyme catalysis system. The enzyme catalysis system with the targeted inhibition function on the growth of the streptococcus mutans is formed by loading AuNPs and PCN-22 (Fe) on a CMD molecular chain through in-situ growth, and the mass ratio of the AuNPs to the PCN-22 (Fe) to the CMD is (0.22%-0.33%) to (12.34%-21.79%) to (77.88%-87.44%). The cascade catalytic effect of the nano-enzyme is adjusted by regulating and controlling the carboxymethyl substitution degree of CMD, so that glucose in a decayed tooth pathological environment is efficiently catalyzed in one step to generate ROS, and damage to probiotics is reduced while the inhibition efficiency of pathogenic bacteria is improved.
Owner:SOUTH CHINA UNIV OF TECH

Application of etoposide in antibacterial preparation and antibacterial preparation

The invention relates to the technical field of antibacterial preparations, and discloses an application of etoposide in an antibacterial preparation and the antibacterial preparation, the antibacterial preparation is a biofilm inhibitor, and etoposide inhibits formation of a biofilm or destroys the formed biofilm by down-regulating gene expression of the bacterial biofilm, so that the antibacterial effect of etoposide is improved. The biofilm is a biofilm of streptococcus mutans ATCC700610, and the biofilm is a biofilm of streptococcus mutans The antibacterial preparation comprises an antibacterial drug, an oral care product, a medical coating and an anti-caries preparation. MIC and MBC determination tests, growth curve tests, crystal violet staining tests, bacterium living / death staining tests and qRT-PCR tests prove that etoposide can effectively down-regulate biofilm related gene expression (such as gtfB, gtfC, gtfD and the like), inhibit formation of a bacterial biofilm or destroy a formed biofilm, and achieve an antibacterial effect.
Owner:NORTH SICHUAN MEDICAL COLLEGE

Application of pantothenic acid in the preparation of anti-caries preparations related to Streptococcus mutans and anti-caries preparations containing pantothenic acid

The present invention discloses the use of pantothenic acid in the preparation of anticaries preparations related to Streptococcus mutans, and anticaries preparations containing pantothenic acid. The invention belongs to the field of biomedicine technology. The anticaries preparations related to Streptococcus mutans include an acid production inhibitor for Streptococcus mutans, a growth inhibitor for Streptococcus mutans, an inhibitor of cariogenic toxins of Streptococcus mutans, and an inhibitor of interspecies competition of Streptococcus mutans. Pantothenic acid can be used to influence the acid production, growth, production of cariogenic toxins, and interspecies competition of Streptococcus mutans, thereby maintaining the balance of the oral microecology.
Owner:SICHUAN UNIV

Use of dacarbazine in the preparation of inhibitors of streptococcus mutans

PendingCN123024083ABiotechnologyBiofilm
The application discloses application of dacarbazine in preparation of an inhibitor of streptococcus mutans and belongs to the technical field of biological medicines. Researches show that the dacarbazine has a significant inhibitory effect on the activity and growth of the streptococcus mutans, can significantly down-regulate the expression of gtfB, gtfC, gtfD, gbpC and / or srtA genes of the streptococcus mutans, and effectively inhibit the formation and activity of a biofilm of the streptococcus mutans. The application provides a new drug selection for the prevention and treatment of the streptococcus mutans and has a wide application prospect in the prevention, improvement and treatment of dental caries in the clinic.
Owner:NORTH SICHUAN MEDICAL COLLEGE

Preparation method and application of erythritol galactoside

The invention relates to a preparation method and application of erythritol galactoside. The method specifically comprises the following steps: constructing a reaction system which takes o-nitrobenzene-beta-D-galactopyranoside as a glycosyl donor, erythritol as a receptor and recombinant beta-galactosidase Bga7 as a catalytic enzyme, so as to prepare the erythritol-beta-galactoside. Wherein the amino acid sequence of the beta-galactosidase Bga7 is as shown in SEQ ID No.2, and the nucleotide sequence of the beta-galactosidase Bga7 is as shown in SEQ ID No.1. The invention also provides an application of the erythritol-beta-galactoside in preparation of daily chemical products or medical preparations for resisting streptococcus mutans infection. The invention provides a novel beta-galactosidase Bga7 gene of a glycosidase family 2, and a novel tool enzyme is provided for synthesis of galactoside products. The erythritol-beta-galactoside prepared by the invention has good effects of preventing streptococcus mutans infection and caries, and can be used for preparing daily chemical products or medical preparations for preventing streptococcus mutans infection.
Owner:HUAZHONG UNIV OF SCI & TECH

Antibacterial polypeptide AuGF and application thereof in preparation of medicine for treating and / or preventing bacterial infection

The invention discloses an antibacterial polypeptide AuGF and application of the antibacterial polypeptide AuGF in preparation of a medicine for treating and / or preventing bacterial infection. The amino acid sequence of the polypeptide is as follows: SEQ ID NO.1: GLFIKIIKIKIAKSF; the antibacterial polypeptide AuGF disclosed by the invention has broad-spectrum antibacterial activity, can effectively solve the problem of bacterial drug resistance, and has a remarkable bacteriostatic effect on various bacteria including staphylococcus aureus, streptococcus mutans, actinobacillus, methicillin-resistant staphylococcus aureus and the like; the compound provided by the invention has the advantages of simple preparation process and low cost, can play a significant role at low concentration, has low minimum inhibitory concentration on various pathogenic bacteria, has strong bacteriostatic ability, and is beneficial to reduction of side effects and improvement of drug safety; the antibacterial polypeptide AuGF can also be used as a bacteriostatic additive to be applied to articles of daily use, provides an effective bacteriostatic means for daily cleaning and skin care, and has a wide market application prospect.
Owner:SOUTHEAST UNIV

A Pediococcus acidilactici YYS-J2 capable of degrading acrylamide and producing high phenyllactic acid and its application

The present invention relates to the field of microbial technology, and provides a Pediococcus acidilactici YYS-J2 that can degrade acrylamide and produce high levels of phenyllactic acid, and its application. Pediococcus acidilactici The preservation number of YYS-J2 is CGMCC No. 28183. This *Pediococcus lactis* YYS-J2 exhibits excellent acrylamide removal capacity, high efficiency in L-phenylalanine utilization and metabolism, high-quality phenyllactic acid production capacity, and excellent *Streptococcus mutans* antibacterial activity. It also produces superoxide dismutase (SOD) and shows good tolerance in simulated gastric and intestinal fluids. This *Pediococcus lactis* YYS-J2 can provide a new probiotic source for the development of functional products such as acrylamide removal products, antibacterial products, and SOD-producing products, and has significant application value.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Streptococcus mutans detection kit and detection method based on anchored CRISPR-Cas12a enhanced paper-based microfluidic chip

The invention relates to the technical field of biological analysis and detection, and particularly discloses a streptococcus mutans detection kit based on an anchored CRISPR-Cas12a enhanced paper-based micro-fluidic chip and a detection method. The detection kit comprises an RAA solution or RAA freeze-dried powder, magnesium acetate or a magnesium acetate solution, TMB or a TMB solution, an RAA forward primer, an RAA reverse primer, a cell lysis buffer, a buffer system and a paper-based micro-fluidic chip. The detection method comprises the following steps: establishing a standard curve and detecting a sample. The detection kit is used for detecting the content of streptococcus mutans and has the characteristics of high efficiency, rapidness, specificity, sensitivity, portability and the like, and the method is simple and convenient to operate, low in detection cost and capable of being applied to on-site detection of streptococcus mutans.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE HAINAN HOSPITAL (HAINAN BOAO RESEARCH HOSPITAL) +1

Method for improving sensitivity of streptococcus mutans to glycyrrhiza uralensis extract

The invention belongs to the technical field of traditional Chinese medicines, and relates to a method for improving the sensitivity of streptococcus mutans to a glycyrrhiza uralensis extract. According to the method, the glycyrrhiza uralensis extract and hydrogen ions jointly act on streptococcus mutans in an acid environment. Research finds that the inhibitory activity of part of the effective components of the glycyrrhiza uralensis extract on streptococcus mutans in an acid environment is remarkably enhanced. The glycyrrhiza uralensis extract and hydrogen ions have a synergistic effect, and the acidic environment can improve the sensitivity of the isostreptococcus to the glycyrrhiza uralensis extract and enhance the bactericidal effect.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE +1